Greenlight Capital GAIN THERAPEUTICS INC ownership

GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 24 filers reported holding GAIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Greenlight Capital ownership history of GAIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$1,781
-9.5%
546,5600.0%0.13%
-17.6%
Q2 2022$1,967
-12.0%
546,5600.0%0.15%
+7.7%
Q1 2022$2,236
-24.7%
546,5600.0%0.14%
-16.5%
Q4 2021$2,968
-27.1%
546,5600.0%0.17%
-37.7%
Q3 2021$4,069
-25.6%
546,5600.0%0.27%
-20.4%
Q2 2021$5,466
-33.0%
546,5600.0%0.34%
-39.6%
Q1 2021$8,155546,5600.57%